SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-18-310644
Filing Date
2018-10-29
Accepted
2018-10-29 16:36:58
Documents
3
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-K/A d643405d10ka.htm 10-K/A 560715
2 EX-31.1 d643405dex311.htm EX-31.1 3868
3 EX-31.2 d643405dex312.htm EX-31.2 3851
  Complete submission text file 0001193125-18-310644.txt   569652
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 000-51122 | Film No.: 181144624
SIC: 3826 Laboratory Analytical Instruments
Office of Life Sciences